MBOT Stock Overview
Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Microbot Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.17 |
52 Week High | US$4.37 |
52 Week Low | US$1.00 |
Beta | 1.65 |
1 Month Change | -7.11% |
3 Month Change | -12.03% |
1 Year Change | -49.57% |
3 Year Change | -85.17% |
5 Year Change | -85.15% |
Change since IPO | -99.23% |
Recent News & Updates
Recent updates
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Dec 30Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Sep 01Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Dec 28Microbot Medical acquires Nitiloop, terms undisclosed
Oct 07Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Sep 13Microbot Medical confirms GLP trial on track to begin later this month
Sep 02Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?
Apr 23Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier
Jan 06Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
Dec 24We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Aug 27Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
May 12We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Jan 27Microbot Medical's study of surgical robotic system meets endpoints
Jan 14Shareholder Returns
MBOT | US Medical Equipment | US Market | |
---|---|---|---|
7D | 7.3% | -0.2% | 1.3% |
1Y | -49.6% | 10.6% | 29.8% |
Return vs Industry: MBOT underperformed the US Medical Equipment industry which returned 11.2% over the past year.
Return vs Market: MBOT underperformed the US Market which returned 30.4% over the past year.
Price Volatility
MBOT volatility | |
---|---|
MBOT Average Weekly Movement | 19.2% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MBOT's share price has been volatile over the past 3 months.
Volatility Over Time: MBOT's weekly volatility has decreased from 27% to 19% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 18 | Harel Gadot | https://www.microbotmedical.com |
Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Microbot Medical Inc. Fundamentals Summary
MBOT fundamental statistics | |
---|---|
Market cap | US$15.94m |
Earnings (TTM) | -US$10.58m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.5x
P/E RatioIs MBOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MBOT income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$10.58m |
Earnings | -US$10.58m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.79 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did MBOT perform over the long term?
See historical performance and comparison